JP2016512830A5 - - Google Patents

Download PDF

Info

Publication number
JP2016512830A5
JP2016512830A5 JP2016501535A JP2016501535A JP2016512830A5 JP 2016512830 A5 JP2016512830 A5 JP 2016512830A5 JP 2016501535 A JP2016501535 A JP 2016501535A JP 2016501535 A JP2016501535 A JP 2016501535A JP 2016512830 A5 JP2016512830 A5 JP 2016512830A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
alkyl
independently
cooh
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016501535A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016512830A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/024436 external-priority patent/WO2014150873A1/en
Publication of JP2016512830A publication Critical patent/JP2016512830A/ja
Publication of JP2016512830A5 publication Critical patent/JP2016512830A5/ja
Pending legal-status Critical Current

Links

JP2016501535A 2013-03-15 2014-03-12 終末糖化産物(age)前駆体の捕捉剤 Pending JP2016512830A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361792719P 2013-03-15 2013-03-15
US61/792,719 2013-03-15
PCT/US2014/024436 WO2014150873A1 (en) 2013-03-15 2014-03-12 Sequestrants of advanced glycation end product (age) precursors

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018083623A Division JP2018135365A (ja) 2013-03-15 2018-04-25 終末糖化産物(age)前駆体の捕捉剤

Publications (2)

Publication Number Publication Date
JP2016512830A JP2016512830A (ja) 2016-05-09
JP2016512830A5 true JP2016512830A5 (enExample) 2017-03-30

Family

ID=50439508

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2016501535A Pending JP2016512830A (ja) 2013-03-15 2014-03-12 終末糖化産物(age)前駆体の捕捉剤
JP2018083623A Pending JP2018135365A (ja) 2013-03-15 2018-04-25 終末糖化産物(age)前駆体の捕捉剤
JP2019220818A Pending JP2020055850A (ja) 2013-03-15 2019-12-06 終末糖化産物(age)前駆体の捕捉剤
JP2021204770A Pending JP2022037143A (ja) 2013-03-15 2021-12-17 終末糖化産物(age)前駆体の捕捉剤

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2018083623A Pending JP2018135365A (ja) 2013-03-15 2018-04-25 終末糖化産物(age)前駆体の捕捉剤
JP2019220818A Pending JP2020055850A (ja) 2013-03-15 2019-12-06 終末糖化産物(age)前駆体の捕捉剤
JP2021204770A Pending JP2022037143A (ja) 2013-03-15 2021-12-17 終末糖化産物(age)前駆体の捕捉剤

Country Status (24)

Country Link
US (2) US20160024233A1 (enExample)
EP (1) EP2968403A1 (enExample)
JP (4) JP2016512830A (enExample)
KR (1) KR20150130492A (enExample)
CN (1) CN105188718A (enExample)
AR (1) AR095593A1 (enExample)
AU (2) AU2014235500A1 (enExample)
BR (1) BR112015023404A8 (enExample)
CA (1) CA2906501A1 (enExample)
CL (1) CL2015002624A1 (enExample)
CR (1) CR20150545A (enExample)
DO (1) DOP2015000221A (enExample)
EA (1) EA201591733A1 (enExample)
HK (1) HK1220607A1 (enExample)
IL (1) IL241406A0 (enExample)
MA (1) MA38487A1 (enExample)
MX (1) MX2015012843A (enExample)
PE (1) PE20151766A1 (enExample)
PH (1) PH12015502019A1 (enExample)
SG (2) SG11201506413PA (enExample)
TN (1) TN2015000390A1 (enExample)
TW (1) TW201521744A (enExample)
UY (1) UY35441A (enExample)
WO (1) WO2014150873A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA41202A (fr) * 2014-12-18 2017-10-24 Genzyme Corp Copolymères polydiallymine réticulé pour le traitement du diabète de type 2
BR112020003638A2 (pt) * 2017-08-31 2020-09-01 Cytosorbents Corporation redução de produtos finais de glicação avançada a partir de fluidos corporais

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5985938A (en) * 1997-11-05 1999-11-16 Geltex Pharmaceuticals, Inc. Method for reducing oxalate
ES2637020T3 (es) * 2001-04-18 2017-10-10 Genzyme Corporation Uso de polímero de amina para reducir la glucosa sérica
AU2003263010A1 (en) * 2003-09-02 2005-04-21 Genzyme Corporation Method for reducing vascular inflammation
US7459502B2 (en) * 2003-11-03 2008-12-02 Ilypsa, Inc. Pharmaceutical compositions comprising crosslinked polyamine polymers
US7385012B2 (en) * 2003-11-03 2008-06-10 Ilypsa, Inc. Polyamine polymers
JP2007523908A (ja) * 2004-02-17 2007-08-23 ダイナミス セラピューティクス インコーポレイテッド フルクトサミン3キナーゼ並びにコラーゲン及びエラスチンの形成
FR2883873B1 (fr) * 2005-03-31 2009-07-10 Pharmamens Sarl Inhibiteurs d'age
US9181364B2 (en) * 2010-02-24 2015-11-10 Relypsa, Inc. Crosslinked polyvinylamine, polyallylamine, and polyethyleneimine for use as bile acid sequestrants

Similar Documents

Publication Publication Date Title
JP2016514192A5 (enExample)
JP2017537066A5 (enExample)
JP2015505296A5 (enExample)
JP2015024998A5 (enExample)
JP2017525730A5 (enExample)
JP2016153410A5 (enExample)
JP2013032389A5 (enExample)
JP2010527913A5 (enExample)
JP2014511891A5 (enExample)
JP2008533007A5 (enExample)
JP2013518107A5 (enExample)
JP2013510120A5 (enExample)
JP2017533930A5 (enExample)
JP2013519683A5 (enExample)
JP2012072150A5 (enExample)
JP2016515561A5 (enExample)
JP2015530389A5 (enExample)
JP2016526558A5 (enExample)
JP2015512931A5 (enExample)
JP2012502037A5 (enExample)
JP2015098469A5 (enExample)
JP2013506674A5 (enExample)
JP2014526533A5 (enExample)
JP2016537338A5 (enExample)
JP2019513829A5 (enExample)